The University of Chicago Header Logo

Connection

Louis Philipson to Potassium Channels, Inwardly Rectifying

Back to Details
This is a "connection" page, showing publications Louis Philipson has written about Potassium Channels, Inwardly Rectifying.
Louis Philipson
Connection Strength
2.118
Potassium Channels, Inwardly Rectifying
  1. Action potentials and insulin secretion: new insights into the role of Kv channels. Diabetes Obes Metab. 2007 Nov; 9 Suppl 2:89-98.
    View in: PubMed
    Score: 0.281
  2. A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life. Diabetologia. 2024 May; 67(5):940-951.
    View in: PubMed
    Score: 0.218
  3. Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes. Sci Rep. 2021 11 03; 11(1):21590.
    View in: PubMed
    Score: 0.186
  4. Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA. J Clin Endocrinol Metab. 2018 01 01; 103(1):35-45.
    View in: PubMed
    Score: 0.142
  5. Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive KCNJ11-Related Diabetes. J Clin Endocrinol Metab. 2017 01 01; 102(1):1-5.
    View in: PubMed
    Score: 0.133
  6. K+ channels: generating excitement in pancreatic beta-cells. Diabetes. 1996 Jul; 45(7):845-53.
    View in: PubMed
    Score: 0.128
  7. Patients with KCNJ11-related diabetes frequently have neuropsychological impairments compared with sibling controls. Diabet Med. 2016 10; 33(10):1380-6.
    View in: PubMed
    Score: 0.128
  8. ATP-sensitive K+ channels: paradigm lost, paradigm regained. Science. 1995 Nov 17; 270(5239):1159.
    View in: PubMed
    Score: 0.123
  9. Functional expression of an epitope-tagged G protein-coupled K+ channel (GIRK1). J Biol Chem. 1995 Jun 16; 270(24):14604-10.
    View in: PubMed
    Score: 0.119
  10. Pas de deux or more: the sulfonylurea receptor and K+ channels. Science. 1995 Apr 21; 268(5209):372-3.
    View in: PubMed
    Score: 0.118
  11. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes. Diabetologia. 2015 Jul; 58(7):1430-5.
    View in: PubMed
    Score: 0.118
  12. Update on diabetes classification. Med Clin North Am. 2015 Jan; 99(1):1-16.
    View in: PubMed
    Score: 0.115
  13. Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect. Diabetes Care. 2009 Aug; 32(8):1428-30.
    View in: PubMed
    Score: 0.078
  14. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes. 2008 Oct; 9(5):450-9.
    View in: PubMed
    Score: 0.074
  15. 5-amino-imidazole carboxamide riboside acutely potentiates glucose-stimulated insulin secretion from mouse pancreatic islets by KATP channel-dependent and -independent pathways. Biochem Biophys Res Commun. 2005 May 20; 330(4):1073-9.
    View in: PubMed
    Score: 0.059
  16. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014 Dec; 99(12):E2709-14.
    View in: PubMed
    Score: 0.029
  17. Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA. Mol Pharmacol. 1994 May; 45(5):854-60.
    View in: PubMed
    Score: 0.028
  18. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment. Curr Diab Rep. 2011 Dec; 11(6):519-32.
    View in: PubMed
    Score: 0.023
  19. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A. 2007 Sep 18; 104(38):15040-4.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.